0.291
price down icon0.27%   -0.0008
after-market アフターアワーズ: .28 -0.011 -3.78%
loading

Cara Therapeutics Inc (CARA) 最新ニュース

pulisher
01:41 AM

Cara Operations (TSE:CARA) Stock Price Down 2.4% – Here’s Why - Defense World

01:41 AM
pulisher
Nov 01, 2024

Cara Therapeutics, Inc.'s (NASDAQ:CARA) Share Price Is Matching Sentiment Around Its Revenues - Simply Wall St

Nov 01, 2024
pulisher
Oct 31, 2024

Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Oct 31, 2024
pulisher
Oct 30, 2024

CSL Limited Reports 13.5% Stake In Cara Therapeutics - XM

Oct 30, 2024
pulisher
Oct 16, 2024

Truist Financial Initiates Coverage on Amentum (NYSE:AMTM) - Defense World

Oct 16, 2024
pulisher
Oct 16, 2024

América Móvil (NYSE:AMX) PT Lowered to $20.80 - Defense World

Oct 16, 2024
pulisher
Oct 16, 2024

Riskified Ltd. (NYSE:RSKD) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Oct 16, 2024
pulisher
Oct 13, 2024

Heritage Global Inc. (NASDAQ:HGBL) Shares Acquired by Dimensional Fund Advisors LP - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Dimensional Fund Advisors LP Purchases 55,636 Shares of VirTra, Inc. (NASDAQ:VTSI) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Reduces Position in Cara Therapeutics, Inc. (NASDAQ:CARA) - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

Opioid Use Disorder (OUD) Market Report 2024: Growth, Trends, Competitive Outlook to 2033 - WhaTech

Oct 10, 2024
pulisher
Oct 09, 2024

Europe Pruritus Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 09, 2024
pulisher
Oct 07, 2024

Financial Health Report: Cara Therapeutics Inc (CARA)’s Ratios Tell a Tale - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

What technical indicators reveal about CARA stock - US Post News

Oct 07, 2024
pulisher
Oct 04, 2024

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Quantisnow

Oct 04, 2024
pulisher
Oct 04, 2024

Medical Marijuana Market Report 2024Growth, Forecast In The Latest Research - WhaTech

Oct 04, 2024
pulisher
Oct 04, 2024

Cara Therapeutics (NASDAQ:CARA) Receives New Coverage from Analysts at StockNews.com - Defense World

Oct 04, 2024
pulisher
Sep 30, 2024

Market Recap: Cara Therapeutics Inc (CARA)’s Positive Momentum, Closing at 0.31 - The Dwinnex

Sep 30, 2024
pulisher
Sep 29, 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Sees Large Increase in Short Interest - Defense World

Sep 29, 2024
pulisher
Sep 26, 2024

Stock Analysts’ New Coverage for September 26th (AINC, AIRI, APTO, BLK, CARA, CBOE, CLLS, CME, CMLS, CTLT) - Defense World

Sep 26, 2024
pulisher
Sep 25, 2024

G-Protein Coupled Receptors Market Growth Analysis, Trends, Share, Market Size And Forecast To 2033 - WhaTech

Sep 25, 2024
pulisher
Sep 23, 2024

A closer look at Cara Therapeutics Inc (CARA) is warranted - US Post News

Sep 23, 2024
pulisher
Sep 21, 2024

WesBanco, Inc. (NASDAQ:WSBC) Receives Consensus Rating of “Hold” from Analysts - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Pruritus Clinical Trials 2024: FDA Approvals, Medication, - openPR

Sep 19, 2024
pulisher
Sep 18, 2024

Ra capital executives buy Bicara Therapeutics shares for $32.99m By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 18, 2024

Aclaris Therapeutics neutral rating reiterated on phase 2a trial - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

Federated Hermes Inc. Acquires Shares of 670,468 Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Carmat launches capital increase, stock plummets - Marketscreener.com

Sep 18, 2024
pulisher
Sep 17, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAGE - PR Newswire

Sep 17, 2024
pulisher
Sep 17, 2024

Most Promising New Drugs for Hidradenitis Suppurativa, with Raj Chovatiya, MD, PhD - MD Magazine

Sep 17, 2024
pulisher
Sep 16, 2024

The time has not yet come to remove your chips from the table: Cara Therapeutics Inc (CARA) - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

Cara Therapeutics Inc (CARA)’s Day in Review: Closing at 0.26, Down by -2.85 - The Dwinnex

Sep 16, 2024
pulisher
Sep 11, 2024

CARA’s Stock Market Adventure: -62.18% YTD Growth Amidst Volatility - The InvestChronicle

Sep 11, 2024
pulisher
Sep 11, 2024

How to interpret Cara Therapeutics Inc (CARA)’s stock chart patterns - US Post News

Sep 11, 2024
pulisher
Sep 11, 2024

Pruritus Therapeutics Market Competition & Segment Analysis – Actavis Plc, Amgen Inc., Bristol-Myers Squibb, Cara Therapeutics, Cipla – Cauverynews - Cauverynews

Sep 11, 2024
pulisher
Sep 10, 2024

Metric Deep Dive: Understanding Cara Therapeutics Inc (CARA) Through its Ratios - The Dwinnex

Sep 10, 2024
pulisher
Sep 09, 2024

Pruritus Pipeline Analysis 2024: FDA Approvals and Emerging - openPR

Sep 09, 2024
pulisher
Sep 02, 2024

Does Cara Therapeutics Inc (CARA) offer a good opportunity for investors? - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Cara Therapeutics (NASDAQ:CARA) Now Covered by Analysts at StockNews.com - Defense World

Sep 02, 2024
pulisher
Aug 30, 2024

Following more layoffs, Stamford’s Cara Therapeutics considers ‘strategic alternatives,’ including dissolving company - Hartford Business Journal

Aug 30, 2024
pulisher
Aug 28, 2024

Analysts review Cara Therapeutics Inc’s rating - Knox Daily

Aug 28, 2024
pulisher
Aug 27, 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Given Consensus Rating of “Hold” by Brokerages - Defense World

Aug 27, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Reduces Position in Cara Therapeutics, Inc. (NASDAQ:CARA) - Defense World

Aug 20, 2024
pulisher
Aug 19, 2024

CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Aug 19, 2024
pulisher
Aug 17, 2024

Cara Therapeutics (NASDAQ:CARA) Coverage Initiated by Analysts at StockNews.com - Defense World

Aug 17, 2024
pulisher
Aug 17, 2024

Cara Therapeutics (NASDAQ:CARA) Issues Quarterly Earnings Results, Misses Estimates By $0.10 EPS - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

Cara: Q2 Earnings Snapshot - San Antonio Express-News

Aug 16, 2024
pulisher
Aug 07, 2024

Investing in Cara Therapeutics Inc (CARA) Is Getting More Attractive - Knox Daily

Aug 07, 2024
pulisher
Aug 07, 2024

Understanding the Risks of Investing in Gain Therapeutics Inc (GANX) - Knox Daily

Aug 07, 2024
pulisher
Aug 03, 2024

Cara Therapeutics receives Nasdaq compliance extension - Investing.com India

Aug 03, 2024
pulisher
Aug 03, 2024

Cara Therapeutics CEO sells over $1,400 in stock - Investing.com India

Aug 03, 2024
pulisher
Aug 03, 2024

Cara Therapeutics receives Nasdaq compliance extension By Investing.com - Investing.com Australia

Aug 03, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):